Based on our clinical experiences, malignancy of breast cancer is closely associated with tumor size, subtype, TNM stage, lymph node metastasis, vascular invasion, and expression of other biomarkers (such as ER, PR HER-2, and Ki67); however, we failed to find any statistical significance between neogenin expression and these prognostic factors. The gene discussed is ESR1; the disease is breast cancer.